Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04177927
Other study ID # 053
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2019
Est. completion date October 1, 2020

Study information

Verified date October 2021
Source Istanbul Medeniyet University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Does Endtidalcarbondioxide Monitoring in Gastrointestinal Endoscopy Have a Clinical Advantage?


Description:

This study will be randomized prospectively and conducted in Sancaktepe Prof.Dr. Dr. İlhan Varank Training and Research Hospital Endoscopy Unit. After the approval from institute ethics committee, and obtaining written informed consent, sixty patients with ASA I-II who underwent lumbar spinal surgery between 18 and 65 years of age were included in the study. Patients with existing heart and lung disease, liver and kidney failure, morbidly obese, using psychiatric drugs, having malignancy, pregnant and lactating patients will not be included in the study. All patients admitted to the endoscopy unit will be monitorized for noninvasive arterial blood and BiS (Bispectral Index) monitorization. Some of the patients will undergo standard monitoring HR (heart rate) and SpO2 (peripheral oxygen saturation). Other patients will be placed in appropriate nasal cannula Capnostream 20p / Coviden for etCO2 (End tidal CO2), RR (Respitarory rate), SpO2 and PR (heart rate) monitorization. Prior to endoscopic intervention, fentanyl 1mcgr/kg iv and propofol 1mg/kg iv will be administered to patients for sedation. During the procedure, the BiS value will be arranged 60-85 and propofol 10-30 mg will be administered intravenously if necessary. If sedation is insufficient, fentanyl 25 mcg iv will be added. After baseline values are recorded mean arterial pressure, BiS values, etCO2, RR, SpO2, PR, iPi (Integrated Pulmonary Index) score values will be recorded at 5 minute intervals after the procedure has started. At the end of the procedure, ODI (Oxygenesaturation Index), A/Hr (hourly apnea) values will be recorded. Undesirable events like apnea, desaturation will be intervened and duration of it will be recorded. Apnea is described as the breathing stops (ETCO2 = 0mmHg, RR = 0 ) for more than 30 seconds and desaturation is described the fall in SpO2 value below 4% of initial value lasting for at least 4 minutes. When apnea and desaturation are seen, verbal stimulation, jaw lifting maneuver and oxygen flow will be increased. If the apnea and desaturation periods of the patients are prolonged or the SpO2 value falls below 10% of the initial value despite the interventions, the procedure will be terminated and necessary procedures will be performed to ensure airway safety and the study will be terminated. Patients who have completed the endoscopic intervention will be taken to the recovery unit and the Fast-tracking recovery score will be calculated at 10 minute intervals in the first hour. The time that the fast-tracking score is 14 will be recorded. Patients with two consecutive Fast-tracking recovery score values 14 will be discharged. Patients will be called after 24-48 hours and questioned if they have symptoms such as abdominal distension, fever, nausea and vomiting, dizziness and weakness. The satisfaction score to the patient will be questioned; 1:not satisfied at all, 2: not satisfied, 3: neutral, 4:satisfied, 5: very satisfied.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date October 1, 2020
Est. primary completion date July 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - ASA I-II - underwent gastrointestinal endoscopy Exclusion Criteria: - existing heart and lung disease - liver and kidney failure - morbid obese - using psychiatric drugs - having malignancy - pregnant and lactating

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Capnostream 20p / Coviden
The special nasal canule is used for detection carbondioxide from breathe of patients
Rutine monitoring
peripheric Oxygen saturation is monitored.

Locations

Country Name City State
Turkey S.B.U. Sancaktepe Education and Research Hospital I?stanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Medeniyet University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary early detection of adverse events early detection of adverse events in patients who underwent sedation during gastrointestinal endoscopic intervention in the endoscopy unit 30 minutes
Secondary quality of recovery period Fast-tracking recovery score is eveluaed for quality of recovery period 120 minutes
Secondary Patients satisfaction Patients is called for eveluating for their satisfaction. (1:not satisfied at all, 2: not satisfied, 3: neutral, 4:satisfied, 5: very satisfied). 24 hours
See also
  Status Clinical Trial Phase
Completed NCT04901390 - Impact of Yogurt on Gastrointestinal Health, Regularity, and Thoughts N/A
Completed NCT04560595 - Remote Guided Caffeine Reduction N/A
Not yet recruiting NCT05566171 - The Effect of Probiotic Supported Yogurt Consumption on Gastrointestinal Symptoms N/A
Completed NCT04979494 - Association Between SMA Flow and AGI in Critically Ill Patients
Completed NCT04005456 - Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design N/A
Withdrawn NCT02574611 - Use of High Resolution Colonic Manometry in Studying Motility Phase 1
Recruiting NCT04112056 - Post-market Surveillance Study of an Infant Formula Containing Moderately Hydrolyzed Protein and Low Lactose N/A
Completed NCT05765123 - Gastric Emptying Validation Pilot Study (MRI Val)
Active, not recruiting NCT05750433 - Phage 3Determination of Phage/Probiotic Synergistic Effects on Gastrointestinal Health N/A
Not yet recruiting NCT06128785 - Electroacupuncture (EA) Promotes Gastrointestinal Functional Recovery After Radical Colorectal Cancer Surgery N/A
Not yet recruiting NCT04647201 - Study of Biomarkers in Patients of Sepsis Complicated With Gastrointestinal Dysfunction
Completed NCT01828047 - Sublingual Microcirculation and Postoperative Ileus N/A
Completed NCT05309837 - Effect of Polydextrose on Fecal Bulk and Bowel Function in Mildly Constipated Subjects N/A
Not yet recruiting NCT06088940 - The Chemo-Gut Probiotic Trial for Cancer Survivors N/A
Not yet recruiting NCT06376461 - Prospective, Multicentre Study to Validate the GastroIntestinal Dysfunction Score (GIDS) and Describe Prevalence, Outcomes, and Management of Phosphate Disorders in Intensive Care Patients
Completed NCT02486328 - The Effect of Different Sedation Regimes on Cognitive Function in Lower Gastrointestinal System Endoscopy Phase 4
Recruiting NCT05669612 - Promephy - Metabolic Fate of Plant-based Proteins N/A
Completed NCT04187950 - NECTAR Study: Nectar (Honey) Effects on Comfort, Thoughts, and Regularity N/A
Active, not recruiting NCT05418127 - An Efficacy Trial in the Research Area of Gastrointestinal Health & Bloating N/A
Completed NCT04606485 - Does Acupressure Affect Gastrointestinal Function, Pain and Anxiety? N/A